The use of short- and long-acting hypnotics in clinical medicine.
- 1 February 1981
- journal article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 11 (S1), 61S-69S
- https://doi.org/10.1111/j.1365-2125.1981.tb01841.x
Abstract
1 Activity of short- and long-acting benzodiazepines is reviewed with reference to pharmacokinetics and residual sequelae, and to efficacy and adverse effects. 2 Some benzodiazepines may not lead to obvious effects on performance, such as nordiazepam and clobazam, and the persistence of residual sequelae may not relate obviously to elimination half-lives (as with diazepam and possibly flunitrazepam). However, benzodiazepines with mean half-lives less than 8 h may have residual sequelae, whereas hypnotics with mean half-lives greater than 16 h are likely to lead to impared performance and/or anxiolytic effects the next day. 3 Potassium chlorazepate 15 mg, with its long-acting metabolite nordiazepam, would seem to be the drug of choice for insomnia secondary to anxiety. For the insomniac without significant psychopathology, temazepam 10-20 mg, triazolam 0.125-0.25 mg and for occasional use, diazepam 5-10 mg, provide the initial approach. Flurazepam hydrochloride 15-30 mg, nitrazepam 5-10 mg and flunitrazepam 1 mg and above, have persistent residual effects and should be reserved for refractory patients, and for those in whom some impairment of performance the next day would be acceptable. 4 There is little or no evidence to suggest that the proper use of the short-acting hypnotics, triazolam and temazepam, leads to a worsening of sleep on withdrawal. However, some benzodiazepines may lead to disturbances of sleep and/or rebound insomnia, and nitrazepam and flunitrazepam may be implicated.Keywords
This publication has 53 references indexed in Scilit:
- Rebound insomnia. A potential hazard following withdrawal of certain benzodiazepinesJAMA, 1979
- Clinical and Psychometric Effects of Flunitrazepam Observed during the day in Relation to Pharmacokinetic DataPublished by Springer Nature ,1979
- Rebound Insomnia: A New Clinical SyndromeScience, 1978
- Clinical Pharmacokinetics of DiazepamClinical Pharmacokinetics, 1978
- Nitrazepam: lastingly effective but trouble on withdrawal.BMJ, 1976
- Acute Effects of Oxazepam, Diazepam and Methylperone, alone and in Combination with Alcohol on Sedation, Coordination and MoodActa Pharmacologica et Toxicologica, 1976
- Immediate effects on human performance of a 1,5‐genzodiazepine (clobazam) compared with the 1,4‐benzodiazepines, chlordiazepoxide hydrochloride and diazepam.British Journal of Clinical Pharmacology, 1975
- Blood Level Profile in Man following Chronic Oral Administration of Flurazepam HydrochlorideJournal of Pharmaceutical Sciences, 1973
- Persistent Behaviour and Electroencephalographic Changes after Single Doses of Nitrazepam and Amylobarbitone SodiumBMJ, 1970
- Five Weeks to Escape the Sleeping-pill HabitBMJ, 1965